French Post-Marketing Surveillance Survey

French Post-Marketing Surveillance Survey

To assess the safety and effecacy of the Cypher stent ™ & Cypher Select ™ in the normal use of medical practices, within the labeled indications.

Multi-center, retrospective and prospective French register. This register does not impose any constraint on the evaluated population, the procedure, or the required examinations. The local practice routines should be applied.

Inclusion Criteria:

• Patients with symptomatic ischemic heart disease due to de novo lesions (lesions <30 mm vessel reference diameter of 2.25 mm to 5 mm), assessed visually, native coronary arteries.

Exclusion Criteria:

• Patients suffering from coronary heart disease.
• Patients for whom treatment antiplatelet and / or anticoagulant is against the state;
• Patients with injuries incompatible with the full inflation of a balloon angioplasty;
• Transplant patients ;
• Patients with known allergy to Sirolimus, the stainless steel 316L, to polymethacrylates or copolymers polyolefins;